Treatments, Trends, and Outcomes of Acute Myocardial Infarction and Percutaneous Coronary Intervention
Matthew T. Roe(Clinical Research Institute), John S. Rumsfeld(University of Colorado Anschutz Medical Campus), Ralph G. Brindis, John C. Messenger(University of Colorado Anschutz Medical Campus), William S. Weintraub(Unknown), Lloyd W. Klein(University of California, San Francisco), Charles R. McKay(McKay Dee Hospital), Gregg C. Fonarow(UCLA Medical Center), Anita Y. Chen(University of Rochester Medicine), Frederick A. Masoudi(Bristol-Myers Squibb (United States)), Kathleen Hewitt, David Dai, Eric D. Peterson, Christopher P. Cannon(Brigham and Women's Hospital)
Cited by 447
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k